Discovery & Development

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

We speak with the Alzheimer’s Society in the UK about their work. Find out more with The Medicine Maker

NervGen President and CEO Mike Kelly discusses the potential of the company’s investigational drug NVG-291 for spinal cord injury.

CPHI Milan 2024, the premier global event for pharmaceutical professionals, will take place October 8-10 at Fiera Milano.

ADC development is a complex process that can be streamlined – and optimized – by taking the right partnerships and strategies into consideration.

Remembering the achievements in the short but successful life of insulin co-developer and Nobel Prize laureate Frederick Banting.

Large study shows secondary tumors after CAR-T cancer therapies are rare

How one company is hoping to create a functional cure for HIV

AI is generating new drug discovery solutions for a rapidly changing industry

The use of AI in small molecules drug discovery is driving the sector in big ways – but there are big challenges too. Here are five steps to success